RYR3 and myasthenia gravis: Interestingly, a significant RYR3 overexpression was observed in MG thymomas, from both corticosteroid-naïve and -treated patients, compared to the non-MG thymomas, control thymuses, and hyperplastic MG thymuses (Figure 4e,g).